Some new derivatives of 3-ethoxycarbonyl-6-bromo-5-hydroxyindoles were designedand prepared, their antiviral activity were determined in cell culture with virus cytopathic effect assay. The results showed compound Ⅶ b, Ⅶ h exhibited potential antiviral activity. 相似文献
A series of novel tetrazole containing 1,2,3-thiadiazole derivatives were designed and synthesized via Ugi reaction. Their structures were confirmed by melting points, IR, 1H NMR, and HRMS (ESI). Preliminary bioassay indicated that most target compounds exhibited very good direct anti-TMV activity at 100 μg/mL, which was equal to or higher than that of ribavirin. Among them, compounds 4b, 4c and 4i also showed equivalent protection effect to ribavirin in vivo at 100 μg/mL. 相似文献
In this paper, we propose a coupled awareness—epidemic spreading model considering the heterogeneity of individual influences, which aims to explore the interaction between awareness diffusion and epidemic transmission. The considered heterogeneities of individual influences are threefold: the heterogeneity of individual influences in the information layer, the heterogeneity of individual influences in the epidemic layer and the heterogeneity of individual behavioral responses to epidemics. In addition, the individuals’ receptive preference for information and the impacts of individuals’ perceived local awareness ratio and individuals’ perceived epidemic severity on self-protective behavior are included. The epidemic threshold is theoretically established by the microscopic Markov chain approach and the mean-field approach. Results indicate that the critical local and global awareness ratios have two-stage effects on the epidemic threshold. Besides, either the heterogeneity of individual influences in the information layer or the strength of individuals’ responses to epidemics can influence the epidemic threshold with a nonlinear way. However, the heterogeneity of individual influences in the epidemic layer has few effect on the epidemic threshold, but can affects the magnitude of the final infected density.